Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center.

Conghui GuanSongbo FuDonghu ZhenKuan YangJinyang AnYapei WangChengxu MaNa JiangNan ZhaoJinjin LiuFang YangXulei Tang

Published in: Journal of diabetes research (2022)

MAFLD is a very common condition and generally had greater frequency of metabolic characteristics among type 2 diabetics in China. Many MAFLD patients were in the "indeterminate" or "high" stage when APRI, FIB-4, and NFS were assessed. Assessment of MAFLD should be included in the management of type 2 diabetes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
oxidative stress
peritoneal dialysis
quality improvement
metabolic syndrome
fatty acid
patient reported